Back to top
more

Sensus Healthcare (SRTS)

(Delayed Data from NSDQ)

$6.69 USD

6.69
62,237

+0.14 (2.14%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $6.73 +0.04 (0.60%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Factors that Make Molina Healthcare (MOH) an Attractive Bet Now

by Zacks Equity Research

Molina Healthcare (MOH) continues to ride on sustained top-line growth, well-performing Medicare and Medicaid businesses, and a strong cash position.

Is the Options Market Predicting a Spike in Sensus Healthcare (SRTS) Stock?

by Zacks Equity Research

Investors need to pay close attention to Sensus Healthcare (SRTS) stock based on the movements in the options market lately.

HCA Healthcare (HCA) Boosts Cancer Portfolio With McKesson JV

by Zacks Equity Research

HCA Healthcare (HCA) inks a joint venture with McKesson to strengthen the cancer offerings suite of both partners. The move will offer HCA the chance to capitalize on the growing cancer therapeutics market.

Anthem (ANTM) Unveils Two Brands to Boost Whole Person Health

by Zacks Equity Research

Anthem (ANTM) launches Carelon and Wellpoint brands to streamline its products and services portfolio as well as bring about enhanced health plans for clients and consumers.

Has Altimmune (ALT) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Altimmune, Inc. (ALT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.

Wall Street Analysts Believe Sensus Healthcare, Inc. (SRTS) Could Rally 55%: Here's is How to Trade

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 54.6% in Sensus Healthcare, Inc. (SRTS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Why Sensus Healthcare, Inc. (SRTS) Might be Well Poised for a Surge

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Wall Street Analysts Think Sensus Healthcare, Inc. (SRTS) Could Surge 53%: Read This Before Placing a Bet

by Zacks Equity Research

The consensus price target hints at a 52.9% upside potential for Sensus Healthcare, Inc. (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Assertio (ASRT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.

Sensus Healthcare, Inc. (SRTS) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 233.33% and 65.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Assertio (ASRT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.

Here's Why "Trend" Investors Would Love Betting on Sensus Healthcare, Inc. (SRTS)

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Sensus Healthcare, Inc. (SRTS) Moves 7.3% Higher: Will This Strength Last?

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Here's Why Sensus Healthcare, Inc. (SRTS) Could be Great Choice for a Bottom Fisher

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Sensus Healthcare, Inc. (SRTS) Just Overtook the 20-Day Moving Average

by Zacks Equity Research

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

What Makes Sensus Healthcare, Inc. (SRTS) a Good Fit for "Trend Investing"

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Will Sensus Healthcare, Inc. (SRTS) Gain on Rising Earnings Estimates?

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Sensus Healthcare, Inc. (SRTS) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

VeriSign (VRSN) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

Higher .com and .net domain name registrations supported by a recovering global economy might have aided VeriSign's (VRSN) performance in the fourth quarter of 2021.

Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks.com featured highlights include: Sensus Healthcare, Inc., Stride, Inc., Euroseas Ltd. and Vocera Communications, Inc

by Zacks Equity Research

Sensus Healthcare, Inc., Stride, Inc., Euroseas Ltd. and Vocera Communications, Inc are highlighted in this Screen of the Week article.

Here's Why "Trend" Investors Would Love Betting on Sensus Healthcare, Inc. (SRTS)

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Nilanjan Banerjee headshot

Buy These 4 Low-Beta Stocks to Sail Through the Choppy Market

by Nilanjan Banerjee

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Stride, Inc. (LRN), Euroseas Ltd. (ESEA) and Vocera (VCRA) are well poised to gain.

Is Aptinyx Inc. (APTX) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Aptinyx Inc. (APTX) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.